ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,706Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 253

$496K Total Retail Price of All Prescriptions

Rank: 3 out of 253

377 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

33% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 32%.

Risky Drugs to Seniors

3% of this provider’s 7,891 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 11%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $37 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 4.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
FUROSEMIDE 423 361 1 8
AMLODIPINE BESYLATE 270 220 2 7
OMEPRAZOLE 258 216 3 2
HYDROCODONE-ACETAMINOPHEN 235 165 S3 4 1
TRAMADOL HCL 227 169 5 3
KLOR-CON M20 223 150 6 95
SIMVASTATIN 222 202 7 5
LISINOPRIL 219 187 8 4
GLIPIZIDE 193 162 9 50
DONEPEZIL HCL 185 185 10 31
POTASSIUM CHLORIDE 168 166 11 14
GABAPENTIN 160 116 12 10
RISPERIDONE 158 105 13 94
CLONIDINE HCL 152 121 14 26
NAMENDA 152 133 14 55
LANTUS 151 121 16 40
QUETIAPINE FUMARATE 150 120 17 54
MIRTAZAPINE 146 146 18 49
LEVOTHYROXINE SODIUM 144 122 19 6
LEVETIRACETAM 140 91 20 83
CARVEDILOL 121 120 21 18
WARFARIN SODIUM 114 114 22 13
HYDROCHLOROTHIAZIDE 114 93 22 11
MELOXICAM 109 92 24 12
CITALOPRAM HBR 105 93 25 41
LEVEMIR 92 73 26 106
IBUPROFEN 92 55 26 65
METFORMIN HCL 91 32 28 9
METOPROLOL TARTRATE 90 85 29 24
NOVOLOG 86 67 30 102
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 64 31 23
NOVOLIN R 83 64 32 170
HYDRALAZINE HCL 82 71 33 88
RANITIDINE HCL 80 70 34 47
VALPROIC ACID 71 45 35 129
DIVALPROEX SODIUM 69 43 36 110
ESCITALOPRAM OXALATE 68 52 37 66
NOVOLIN 70-30 67 67 38 189
CLOPIDOGREL 66 58 39 53
PROMETHAZINE HCL 65 61 R 40 38
CIPROFLOXACIN HCL 64 52 41 36
PANTOPRAZOLE SODIUM 62 61 42 35
SERTRALINE HCL 57 57 43 42
PRAVASTATIN SODIUM 55 47 44 21
TAMSULOSIN HCL 54 53 45 58
TRIAMCINOLONE ACETONIDE 54 49 45 207
PREDNISONE 53 46 47 16
OXYBUTYNIN CHLORIDE ER 53 53 47 142
OLANZAPINE 52 52 49 210
KLOR-CON M10 52 52 49 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.